drugset / Trial / NCT01743404
Study of Anti-atherosclerotic Activity of Inflaminat in Asymptomatic Participants With Subclinical Atherosclerosis
RandomizedParallel-groupDouble-blindPrevention
Summary
The purpose of this study is to investigate the anti-atherosclerotic effect of long-term anti-inflammatory therapy (Inflaminat) in asymptomatic participants with subclinical atherosclerosis of carotid arteries.
Timeline
- Start
- 2007-09
- Primary completion
- 2013-02
- Completion
- 2013-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Inflaminat | Unknown | 500 mg | Oral |